• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

HSAs thrive with financial partners

Article

Health plans that coordinate their health savings account offerings with banks increase the likelihood that individuals establish and contribute to an HSA account, experts say.

"It is important for managed care executives to understand the product they are offering," says Paul Fronstin, director, health research and education program, Employee Benefit Research Institute (EBRI). "HSAs are often offered by health plans. In fact, some plans are buying banks to offer the HSA in a more integrated way with the health plan. HSAs are also being 'advertised' as a way to address healthcare costs in retirement. Given that savings needed for healthcare in retirement are much higher than potential HSA savings [see chart], it will make it harder for managed care executives to sell HSAs as the sole solution to healthcare costs in retirement. However, there are opportunities to work with financial planners to better educate the public and investors."

This chart from EBRI shows the amount of money individuals and families can save in an HSA if they make the maximum contribution, based on how much is rolled over each year.

"Whether true or not, we see the insurance and financial services industries coming together to finance healthcare in complementary ways. Some are threatened by that, but we are kidding ourselves if we believe insurance is the only way to finance healthcare spending," continues Ramthun, who led the U.S. Treasury Department's implementation of HSAs since their creation in 2003, then became the senior health policy advisor to President Bush.

Ramthun believes that if sufficient funds for healthcare are to be accumulated in retirement, HSAs offer a significant vehicle to supplement existing vehicles, such as 401(k) plans and IRAs. "Given that withdrawals from HSAs are tax-free for health and much of long-term care, HSAs offer a critical tax advantage to the other mechanisms."

The automatic rollover of unused funds in HSAs creates asset accumulation that makes people understand how HSAs can be used as a supplement to retirement planning, according to Ramthun. "That changes the focus for many people from 'consumption now' to 'planning for the future,'" he says. "If current consumption is reduced, that will help keep near-term healthcare spending increases down. This in turn, should keep health insurance premiums more affordable for HSA-based products."

Related Videos
Video 9 - "Denial of Coverage in Fertility Care"
Video 8 - "Risks of Miscarriage and Multiple Births Associated with Fertility Care"
Video 7 - "Fertility Preservation: Egg Freezing Versus Embryo Freezing"
Video 6 - "Family Building Costs, Barriers, and Dropout Rates Associated with Fertility Care"
Video 5 - "Closing Payer Gaps and Improving Fertility Care Access"
Video 4 - "Increasing Employer Coverage and Maximizing Fertility Benefits "
Video 5 - "Relevance of NUTURE Study Findings for Patients, Payers, Providers"
Video 3 - "Improving IVF Success Rates & Utilizing AI in Fertility Health Care"
Video 2 - "Holistic Fertility Management and Payer Collaboration"
Video 5 - "Relevance of NUTURE Study Findings for Patients, Payers, Providers"
Related Content
© 2024 MJH Life Sciences

All rights reserved.